184 related articles for article (PubMed ID: 27101076)
1. Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements.
Ulano A; Bredella MA; Burke P; Chebib I; Simeone FJ; Huang AJ; Torriani M; Chang CY
AJR Am J Roentgenol; 2016 Aug; 207(2):362-8. PubMed ID: 27101076
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses.
Elangovan SM; Sebro R
AJR Am J Roentgenol; 2018 Mar; 210(3):615-620. PubMed ID: 29323547
[TBL] [Abstract][Full Text] [Related]
3. CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.
Azar A; Garner HW; Rhodes NG; Yarlagadda B; Wessell DE
AJR Am J Roentgenol; 2021 Apr; 216(4):1022-1030. PubMed ID: 32755207
[No Abstract] [Full Text] [Related]
4. Optimized CT Attenuation and SUV Prediction Thresholds for Differentiating Enostoses From Untreated and Treated Metastases on Attenuation-Corrected 18F-FDG PET/CT.
Lee HT; Pryma DA; Sebro R
Clin Nucl Med; 2020 Jan; 45(1):32-37. PubMed ID: 31693615
[TBL] [Abstract][Full Text] [Related]
5. Bone islands incidentally detected on computed tomography: frequency of enostosis and differentiation from untreated osteoblastic metastases based on CT attenuation value.
Sala F; Dapoto A; Morzenti C; Firetto MC; Valle C; Tomasoni A; Sironi S
Br J Radiol; 2019 Nov; 92(1103):20190249. PubMed ID: 31469323
[TBL] [Abstract][Full Text] [Related]
6. Quantitative contrast-enhanced CT attenuation evaluation of osseous metastases following chemotherapy.
Chang CY; Simeone FJ; Torriani M; Bredella MA
Skeletal Radiol; 2017 Oct; 46(10):1385-1395. PubMed ID: 28667362
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of osteoblastic metastases from bone islands in patients with lung cancer by single-source dual-energy CT: advantages of spectral CT imaging.
Dong Y; Zheng S; Machida H; Wang B; Liu A; Liu Y; Zhang X
Eur J Radiol; 2015 May; 84(5):901-7. PubMed ID: 25661696
[TBL] [Abstract][Full Text] [Related]
9. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values?
Ho LM; Marin D; Neville AM; Barnhart HX; Gupta RT; Paulson EK; Boll DT
AJR Am J Roentgenol; 2012 Apr; 198(4):840-5. PubMed ID: 22451549
[TBL] [Abstract][Full Text] [Related]
10. Detection of renal lesion enhancement with dual-energy multidetector CT.
Neville AM; Gupta RT; Miller CM; Merkle EM; Paulson EK; Boll DT
Radiology; 2011 Apr; 259(1):173-83. PubMed ID: 21292866
[TBL] [Abstract][Full Text] [Related]
11. Variation in Attenuation in L1 Trabecular Bone at Different Tube Voltages: Caution Is Warranted When Screening for Osteoporosis With the Use of Opportunistic CT.
Garner HW; Paturzo MM; Gaudier G; Pickhardt PJ; Wessell DE
AJR Am J Roentgenol; 2017 Jan; 208(1):165-170. PubMed ID: 27762605
[TBL] [Abstract][Full Text] [Related]
12. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
13. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
14. Atypical Enostoses-Series of Ten Cases and Literature Review.
Bedard T; Mohammed M; Serinelli S; Damron TA
Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33065973
[TBL] [Abstract][Full Text] [Related]
15. Uniform vascular enhancement of lower-extremity artery on CT angiography using test-injection monitoring at the central level of the scan range: a simulation flow phantom study with clinical correlation.
Shimizu K; Utsunomiya D; Nakaura T; Awai K; Oda S; Yanaga Y; Funama Y; Hirai T; Hashida M; Yamashita Y
Acad Radiol; 2010 Sep; 17(9):1153-7. PubMed ID: 20605732
[TBL] [Abstract][Full Text] [Related]
16. Effect of Model-Based Iterative Reconstruction on CT Number Measurements Within Small (10-29 mm) Low-Attenuation Renal Masses.
Shampain KL; Davenport MS; Cohan RH; Goodsitt MM; Ellis JH; Platt JF
AJR Am J Roentgenol; 2015 Jul; 205(1):85-9. PubMed ID: 26102384
[TBL] [Abstract][Full Text] [Related]
17. Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation.
Deniffel D; Sauter A; Dangelmaier J; Fingerle A; Rummeny EJ; Pfeiffer D
Eur J Radiol; 2019 Feb; 111():6-13. PubMed ID: 30691666
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
19. Spectral parametric segmentation of contrast-enhanced dual-energy CT to detect bone metastasis: feasibility sensitivity study using whole-body bone scintigraphy.
Lee YH; Kim S; Lim D; Suh JS; Song HT
Acta Radiol; 2015 Apr; 56(4):458-64. PubMed ID: 24714734
[TBL] [Abstract][Full Text] [Related]
20. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT?
Jonisch AI; Rubinowitz AN; Mutalik PG; Israel GM
Radiology; 2007 May; 243(2):445-50. PubMed ID: 17456870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
